Skip to main content
. 2017 Oct 21;174(Suppl Suppl 1):S17–S129. doi: 10.1111/bph.13878
Nomenclature PAC 1 receptor VPAC 1 receptor VPAC 2 receptor
HGNC, UniProt ADCYAP1R1, P41586 VIPR1, P32241 VIPR2, P41587
Potency order of endogenous ligands PACAP‐27 (ADCYAP1, P18509), PACAP‐38 (ADCYAP1, P18509) ≫VIP (VIP, P01282) VIP (VIP, P01282), PACAP‐27 (ADCYAP1, P18509), PACAP‐38 (ADCYAP1, P18509) ≫GHRH (GHRH, P01286), PHI {Pig}, secretin (SCT, P09683) VIP (VIP, P01282), PACAP‐38 (ADCYAP1, P18509), PACAP‐27 (ADCYAP1, P18509) >PHI {Pig} ≫GHRH (GHRH, P01286), secretin (SCT, P09683)
Selective agonists maxadilan [446], maxadilan [446] [Lys15,Arg16,Leu27]VIP‐(1‐7)/GRF‐(8‐27)‐NH 2 [1369], [Ala 11,22,28]VIP [1458] Ro 25‐1553 [669, 930, 1369], Ro 25‐1392 [2144]
Selective antagonists PG 97‐269 (pIC50 8.7) [668, 930]
Labelled ligands [125 I]PACAP‐27 (Agonist) [1581] [125 I]VIP (human, mouse, rat) (Agonist) [1458], [125 I]PACAP‐27 (Agonist) [125 I]VIP (human, mouse, rat) (Agonist) [1458], [125 I]PACAP‐27 (Agonist)